Open Access

Dyslipidaemia and type 2 diabetes - the two ugly sisters

Event: ESC Preventive Cardiology 2021
Topic: Lipids
Session type: Symposium
Date: 17 April 2021
Time: 16:40 - 17:25

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

Dyslipidaemia in type 2 diabetes: scope of the problem.

Speaker: Professor F. Mach (Geneva, CH)
Thumbnail

When statins are not enough: emerging pharmacological tools.

Speaker: Professor U. Landmesser (Berlin, DE)
Thumbnail

SGLT2 inhibitors: beyond their glucose-lowering effects.

Speaker: Professor A. Avogaro (Padova, IT)
Thumbnail

Triglyceride-rich lipoproteins: is weight loss the solution?

Speaker: Professor J. Armitage (Oxford, GB)
Thumbnail

Dyslipidaemia and type 2 diabetes - the two ugly sisters - discussion.

Thumbnail

4 speakers from this session

Professor Francois Mach

Geneva University Hospitals, Geneva (Switzerland)
20 presentations
1 follower

Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)
36 presentations
1 follower

Professor Angelo Avogaro

PADOVA HOSPITAL, Padova (Italy)
5 presentations
0 follower

Professor Jane Armitage

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
10 presentations
2 followers

Related content

ESC Premium Access

ESC Guidelines 2021 - Prevention

4 December 2021

ESC Premium Access

ESC Guidelines 2021 - Valvular Heart Disease

3 December 2021

ESC Premium Access

Personalized Approaches to antiplatelet treatment in ACS-PCI patients

3 December 2021

This platform is supported by

logo Novo Nordisk